Skip to main content

Brummer Multi-Strategy AB

SEC CIK
0002003159
Latest filing
Jul 23, 2026

Holdings changes from Q3 2025 to Q4 2025

Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.

Choose two quarters to compare

New
9
Est. +$12.1M
Added
2
Est. +$1.10M
Reduced
0
Sold out
2
Est. −$1.87M

Portfolio value went from $5.49M to $16.5M (+$11.1M (+201.4%)); positions from 4 to 11 (+7).

All Q4 2025 holdingsAll Q3 2025 holdings

In the shares, value and % of portfolio columns, the top figure is Q4 2025 and the gray one below is Q3 2025. For stocks that split between the two quarters, Q3 2025 shares are converted at the split ratio before comparing.

Holdings of Brummer Multi-Strategy AB in Q3 2025 and Q4 2025 compared
SecurityActionSharesShare changeValueEst. bought or sold% of portfolioWeight change (pp)
NMRKNewmark Group, Inc.AddedHistory200,493189,519+10,974+5.8%$3.48M$3.53M+$190.3K21.0%64.4%−43.38
CICigna GroupNewHistory11,8180+11,818$3.25M$0+$3.25M19.7%0.0%+19.66
ARVNArvinas, Inc.NewHistory166,3420+166,342$1.97M$0+$1.97M11.9%0.0%+11.93
ABVXAbivax S.A.NewHistory14,3750+14,375$1.94M$0+$1.94M11.7%0.0%+11.72
IQVIQVIA Holdings Inc.NewHistory8,1830+8,183$1.84M$0+$1.84M11.1%0.0%+11.15
MRVIMaravai Lifesciences Holdings, Inc.NewHistory457,7070+457,707$1.49M$0+$1.49M9.0%0.0%+8.99
BDXBecton Dickinson & CoAddedHistory5,176470+4,706+1,001.3%$1.00M$88.0K+$913.3K6.1%1.6%+4.47
ATAIAtai Beckley N.V.NewHistory234,9150+234,915$960.8K$0+$960.8K5.8%0.0%+5.81
SLNOSoleno Therapeutics IncNewHistory8,7410+8,741$404.7K$0+$404.7K2.4%0.0%+2.45
GRMLGreenland Mines LtdNewHistory606,7570+606,757$175.4K$0+$175.4K1.1%0.0%+1.06
FHTXFoghorn Therapeutics Inc.NewHistory4,7080+4,708$25.4K$0+$25.4K0.2%0.0%+0.15
PTCTPTC Therapeutics, Inc.Sold outHistory019,142−19,142−100.0%$0$1.17M−$1.17M0.0%21.4%−21.40
CIGIColliers International Group Inc.Sold outHistory04,426−4,426−100.0%$0$691.4K−$691.4K0.0%12.6%−12.60

Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.